What is the best clinical approach to recurrent/refractory osteosarcoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

What is the best clinical approach to recurrent/refractory osteosarcoma?

Published:2020-05-03 Issue:5 Volume:20 Page:415-428
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Meazza Cristina¹,Bastoni Stefano²,Scanagatta Paolo³

Affiliation:

1. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

2. Center for Oncological Orthopedic Surgery, ASST Azienda Ospedaliera Istituto G Pini-CTO, Milano, Italy

3. Thoracic Surgery Division, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2020.1760848

Reference131 articles.

1. Classic Osteosarcoma

2. Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project

3. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of Sintilimab and Anlotinib for Metastatic Osteosarcoma: A Case Report;OncoTargets and Therapy;2024-08

2. A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?;Cancer Treatment Reviews;2023-11

3. Does primary tumor resection improve survival for patients with sarcomas of pelvic bones, sacrum, and coccyx who have metastasis at diagnosis ?;European Spine Journal;2023-10-23

4. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization;Cellular Oncology;2023-09-07

5. Integrated multiomic analysis and high‐throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy;MedComm;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3